Starzl T
Proc Natl Acad Sci U S A. 2004; 101 Suppl 2:14607-14.
PMID: 15319473
PMC: 521985.
DOI: 10.1073/pnas.0404829101.
Gandy K
Immunol Res. 2001; 22(2-3):147-64.
PMID: 11339352
DOI: 10.1385/IR:22:2-3:147.
Groth C, BRENT L, Calne R, Dausset J, GOOD R, Murray J
World J Surg. 2000; 24(7):834-43.
PMID: 10833252
PMC: 2967280.
DOI: 10.1007/s002680010134.
Starzl T
World J Surg. 2000; 24(7):759-82.
PMID: 10833242
PMC: 3091383.
DOI: 10.1007/s002680010124.
Starzl T, Eliasziw M, Gjertson D, Terasaki P, Fung J, Trucco M
Transplantation. 1997; 64(7):983-91.
PMID: 9381546
PMC: 2967288.
DOI: 10.1097/00007890-199710150-00009.
Transplantation immunology of penetrating keratoplasty.
Stark W
Trans Am Ophthalmol Soc. 1980; 78:1079-117.
PMID: 7020213
PMC: 1312166.
Cadaver donor renal transplantation by centers of the Southeastern Organ Procurement Foundation.
McDonald J, Vaughn W, Filo R, Picon G, Niblack G, Spees E
Ann Surg. 1981; 193(1):1-8.
PMID: 7006527
PMC: 1344994.
DOI: 10.1097/00000658-198101000-00001.
Factors associated with outcome of renal transplantation.
Guttmann R
Can Med Assoc J. 1983; 129(11):1195-9.
PMID: 6357418
PMC: 1875544.
The role of blocking antibodies in immunological enhancement.
Takasugi M, Klein E
Immunology. 1971; 21(4):675-84.
PMID: 5121758
PMC: 1408237.
[Tissue typing--basis for clinical organ transplantation].
van Rood J, van Leeuwen A, Freudenberg J, Schippers H
Langenbecks Arch Chir. 1971; 329:716-23.
PMID: 4949858
DOI: 10.1007/BF01770624.
Cyclophosphamide and whole organ transplantation in human beings.
Starzl T, Putnam C, Halgrimson C, Schroter G, Martineau G, Launois B
Surg Gynecol Obstet. 1971; 133(6):981-91.
PMID: 4940540
PMC: 2762737.
Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture.
Ferrone S, Cooper N, Pellegrino M, Reisfeld R
J Exp Med. 1973; 137(1):55-68.
PMID: 4734592
PMC: 2139359.
DOI: 10.1084/jem.137.1.55.
Proceedings: The outcome of kidney retransplantation.
Husberg B, Starzl T
Arch Surg. 1974; 108(4):584-7.
PMID: 4593106
PMC: 3035835.
DOI: 10.1001/archsurg.1974.01350280184030.
[Genetic systems of human histocompatibility: the HL-A system].
Albert E
Blut. 1973; 27(2):73-80.
PMID: 4586835
DOI: 10.1007/BF01631997.
Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients.
Falk R, Guttmann R, Falk J, Beaudoin J, deVeber G, Morehouse D
Clin Exp Immunol. 1973; 14(1):47-56.
PMID: 4577287
PMC: 1553844.
Relationship of mixed lymphocyte culture response to HL-A histocompatibility antigens. Effect of allele plus one antigen match.
Thompson J, Parmely M, Flink R, Canady M, Severson C
J Exp Med. 1972; 135(3):596-609.
PMID: 4550771
PMC: 2139132.
DOI: 10.1084/jem.135.3.596.
Immune responses in vitro. IX. Absence of the mixed leukocyte stimulatory, M-locus product from thymus cells.
Click R
J Exp Med. 1974; 139(6):1628-34.
PMID: 4275313
PMC: 2139686.
DOI: 10.1084/jem.139.6.1628.
Third party mixed-leukocyte culture test: a potential new method of histocompatibility testing.
Park B, GOOD R
Proc Natl Acad Sci U S A. 1972; 69(6):1490-3.
PMID: 4113869
PMC: 426733.
DOI: 10.1073/pnas.69.6.1490.
Cyclophosphamide and human organ transplantation.
Starzl T, Halgrimson C, Penn I, Martineau G, SCHROTER G, Amemiya H
Lancet. 1971; 2(7715):70-4.
PMID: 4103984
PMC: 2790039.
DOI: 10.1016/s0140-6736(71)92046-0.
[Leukocyte antigens and their clinical significance].
Mayr W
Blut. 1975; 31(6):337-42.
PMID: 1106799
DOI: 10.1007/BF01633998.
